Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis.
about
Natural Killer Cells and Liver FibrosisCellular and molecular mechanisms in the pathogenesis of liver fibrosis: An updateLiver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response.The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis CNatural killer and natural killer T cells in liver fibrosisInnate immunity and alcoholic liver fibrosis.Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.New concepts in the pathogenesis of alcoholic liver disease.The immunology of fibrosis: innate and adaptive responses.Activated hepatic stellate cells impair NK cell anti-fibrosis capacity through a TGF-β-dependent emperipolesis in HBV cirrhotic patients.Cell death and fibrogenesis.Roles of liver innate immune cells in nonalcoholic fatty liver disease.Immunological orchestration of liver fibrosis.NK cells in hepatitis B virus infection: a potent target for immunotherapy.Effect of vitamin E succinate on the expression of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor in gastric cancer cells and CD4(+) T cells.Natural killer cells in inflammatory heart disease.Antibody-Directed Glucocorticoid Targeting to CD163 in M2-type Macrophages Attenuates Fructose-Induced Liver Inflammatory Changes.CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivationVitamin C deficiency attenuates liver fibrosis by way of up-regulated peroxisome proliferator-activated receptor-gamma expression in senescence marker protein 30 knockout mice.NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner.Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver Cirrhosis.Innate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases.Ambiguous roles of innate lymphoid cells in chronic development of liver diseases.MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis
P2860
Q26767448-DC6FB532-375D-43E8-96D1-B339F4B924C3Q27027703-743616A4-4ACB-49F0-8081-E8E2C85C79B5Q30374500-B748C45D-A624-42BD-84DA-5D79762475EEQ34335634-F3A9F03D-57C8-4215-A65F-D887C912C07FQ36553227-39F0D823-9722-43BA-BB56-2DB6737A956FQ37108845-3849A579-BBC5-4C42-9D2F-D38A88745036Q37326768-46E57F24-E1F8-4001-B9AE-7D62334CEB6AQ37353086-D7A11340-EFDA-4EDE-B2E8-2DFC2833FC9EQ37682484-8D70638F-2A03-4E7A-9E1C-641487B59EDCQ37698781-93BE6A22-CD2D-42E9-9841-2D7E1C06445CQ37776184-B38E982F-5062-4173-A1A1-F893A5EB95C2Q37793003-DE10740E-08A2-4646-AECF-18B4F092D8FAQ38018539-B08D5BE8-0F11-4F61-9FA0-F600DB09DFD0Q38180372-CAC997A4-D4E1-4DE2-BD55-BCF89E5E6B3CQ38834785-9347291A-51DA-45E6-A1DE-7ADD0083831FQ39022829-9DA6D93A-9896-4982-9757-15A4AB0BF98BQ42284206-7D1FCB59-EFE2-4573-A361-528A43457F9FQ42836727-71D30AA5-61F1-4C31-A5D0-6BA681DF428DQ43159399-3EDC3666-6541-4964-9B13-010502FB90F0Q47980556-2F09ED37-1476-4669-833A-13B696BEA49FQ51713351-7DF2B901-97F9-422F-8331-E4C0462E8F86Q53402699-5FE2328F-84BB-404E-94BF-AA5721570E7FQ55208795-22F7B423-3D10-4597-B309-B940A44C567BQ57107966-47652A7A-9799-4983-9E05-1396AD31AA6D
P2860
Activation of natural killer cells inhibits liver fibrosis: a novel strategy to treat liver fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Activation of natural killer c ...... ategy to treat liver fibrosis.
@en
Activation of natural killer c ...... ategy to treat liver fibrosis.
@nl
type
label
Activation of natural killer c ...... ategy to treat liver fibrosis.
@en
Activation of natural killer c ...... ategy to treat liver fibrosis.
@nl
prefLabel
Activation of natural killer c ...... ategy to treat liver fibrosis.
@en
Activation of natural killer c ...... ategy to treat liver fibrosis.
@nl
P2093
P2860
P356
P1476
Activation of natural killer c ...... ategy to treat liver fibrosis.
@en
P2093
Svetlana Radaeva
Won-Il Jeong
P2860
P304
P356
10.1586/17474124.1.1.173
P577
2007-10-01T00:00:00Z